The change in the level of responsibility in the rehabilitation process of persons suffering from drug addiction by Tatiana A. Serezhko, Natalia M. Volobueva

Subjects: “…drug addiction…”
Get full text

Recent Advances in Peptide-Loaded PLGA Nanocarriers for Drug Delivery and Regenerative Medicine by Hossein Omidian, Renae L. Wilson, Ana M. Castejon

Subjects: Get full text

Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis by Xuan Wang, Shan Han, Lili Zhao, Hongliang Cong

“…However, there is no specific research on the above effects of drug combinations. Therefore, this study aimed to establish a rat CIAKI model with meglumine diatrizoate and add drug intervention to compare the influence of combined drugs with that of atorvastatin alone on CIAKI via the inhibition of ERS-specific molecular chaperones. …”
Get full text

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease by C. J. J. Mulder, S. J. Van Den Hazel

Subjects: Get full text

On QSPR analysis of pulmonary cancer drugs using python-driven topological modeling by Huiling Qin, Mazhar Hussain, Muhammad Farhan Hanif, Muhammad Kamran Siddiqui, Zahid Hussain, Mohamed Abubakar Fiidow

Subjects: “…Pulmonary cancer drugs…”
Get full text

Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development by Negar Seyed, Tahereh Taheri, Farhat Afrin, Hamidreza Majidiani, Hamidreza Majidiani

Subjects: Get full text

Analysis of drug release models from biodegradable nanomodified chitosan based materials by М. О. Кумеда, Л. Б. Суходуб, Л. Ф. Суходуб

Subjects: Get full text

Investigating the Prospects of ChatGPT in Training Medicinal Chemists and the Development of Novel Drugs by Michell O. Almeida, Artur C. G. Soares, Gustavo H. M. Sousa, Witor R. Ferraz, Gustavo Trossini

Subjects: Get full text

Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective by Fahimeh Mirakhori, Sarfaraz K. Niazi

Subjects: Get full text

Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products by Samira Toghanian, John Moshtaghi-Svensson, Maria Papageorgiou, Kristin Kittelsen, Christiaan Dolk, Markus Hultstrand, Stina Salomonsson

“…**Objectives:** This study investigated the impact of generic/biosimilar entry on drug budget in 4 countries. **Methods:** Pharmaceutical sales data, drug costs and LOE dates were modeled and forecast using an analytical framework (Affordability by ReallocaTing Funds model \[ART\]) to estimate future incremental budget availability using scenario analyses in Greece (GR), the Netherlands (NL), Norway (NO) and Sweden (SW). …”
Get full text

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer by M. V. Sedova, M. A. Batov, V. S. Tretyak, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko, A. D. Kaprin

“…International studies have shown the results of the use of targeted (ramucirumab, trastuzumab, pertuzumab), immune drugs (pembrolizumab, nivolumab, ipilimumab), S‑1 in combination with chemotherapy as part of the combined treatment of gastric and esophageal‑ gastric junction cancer. …”
Get full text

Investigation of the Potential of Nanoparticles as a New Drug Delivery System for Endodontic Treatment by Abdul A. K. Kader, Sandeep Chandran, K. K. Ridhun Unnikrishnan, Nikita A. Mannur, Anusar Gupta, Savadamoorthi Kamatchi Subramani

Subjects: Get full text

Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis? by Oliver Distler, Cosimo Bruni, Suzana Jordan, Carina Mihai, Muriel Elhai, Rucsandra Dobrota, Alexandru Garaiman, Mike Oliver Becker, Lea Stamm, Sherif Ismail, Norina Zampatti, Aurora Maria Tatu

Get full text

Reversal gene expression assessment for drug repurposing, a case study of glioblastoma by Shixue Sun, Zeenat Shyr, Kathleen McDaniel, Yuhong Fang, Dingyin Tao, Catherine Z. Chen, Wei Zheng, Qian Zhu

Subjects: Get full text

Optimization of HIV drugs through MCDM technique Analytic Hierarchy Process(AHP). by Fozia Bashir Farooq, Sobia Sultana, Nouf Abdulrahman Alqahtani, Muhammad Imran

“…Topological indices are crucial tools for predicting the physicochemical and biological features of different drugs. They are numerical values obtained from the structure of chemical molecules. …”
Get full text

Surveillance of drug prescribing: why outliers miss their targets – a qualitative study by Julia Gollnick, Nikoletta Zeschick, Franziska Hörbrand, Peter Killian, Maria Sebastiao, Thomas Kühlein, Norbert Donner-Banzhoff

Subjects: “…Drug prescriptions…”
Get full text

The Search for the Optimal Methodology for Predicting Fluorinated Cathinone Drugs NMR Chemical Shifts by Natalina Makieieva, Teobald Kupka, Oimahmad Rahmonov

Get full text

Criteria to define rare diseases and orphan drugs: a systematic review protocol by Katie Kerr, Ghada Mohammed Abozaid, Amy McKnight, Hussain A Al-Omar

“…These conditions can be treated with medications known as orphan drugs (ODs). Unfortunately, there is no universal definition of RDs or ODs. …”
Get full text

Spectrophotometric Determination of Various Drugs Using Chloranilic Acid as Chromogenic Reagent - II by V. Annapurna, G. Jyothi, T. Rohini Kumari, B. B. V. Sailaja

“…Simple, accurate and reproducible visible spectrophotometric method for the assay of drugs such as pyrilamine and fluvoxamine as maleates was established based on the formation of charge-transfer complex and redox reaction between the corresponding drug and substituted p-benzoquinone (chloranilic acid). …”
Get full text

Toxicology and Disease/Cancer Therapy in Reactive Oxygen Species-Mediated Drugs and Treatments by Hsueh-Wei Chang, Shao-Yu Chen, Li-Yeh Chuang, Sanjay Guleria

Get full text